Shares of Ascentage Pharma Group International (NASDAQ:AAPG – Get Free Report) rose 5.1% on Tuesday . The stock traded as high as $23.30 and last traded at $23.07. Approximately 7,171 shares changed hands during mid-day trading, a decline of 91% from the average daily volume of 82,682 shares. The stock had previously closed at $21.95.
Analyst Ratings Changes
Separately, JPMorgan Chase & Co. started coverage on shares of Ascentage Pharma Group International in a research report on Thursday, March 27th. They set an “overweight” rating on the stock.
Check Out Our Latest Stock Report on Ascentage Pharma Group International
Ascentage Pharma Group International Price Performance
About Ascentage Pharma Group International
Ascentage Pharma Group International Co, Ltd. is a clinical-stage biotechnology company. It engages in the development of novel therapies for cancers, hepatitis B virus, or HBV, and age-related diseases. The company was founded by Da Jun Yang, Wang Shao Meng and Ming Guo in May 2009 and is headquartered in Suzhou, China.
Featured Stories
- Five stocks we like better than Ascentage Pharma Group International
- With Risk Tolerance, One Size Does Not Fit All
- Berkshire Hathaway Gains Defy Stock Market Slump
- Transportation Stocks Investing
- Palantir Stock Builds Momentum on New Partnership
- Compound Interest and Why It Matters When Investing
- Tech Sell-Off Makes Microsoft Stock Look Like a Steal
Receive News & Ratings for Ascentage Pharma Group International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ascentage Pharma Group International and related companies with MarketBeat.com's FREE daily email newsletter.
